TMDX Filing
10-QFiling Date: May 5, 2026

TransMedics Group, Inc. (TMDX) · Quarterly Report (10-Q) SEC Filing

10-Q

descriptionView SEC Filing
ACC: 0001193125-26-206453open_in_new
Key Financial Metrics3M Mar'26 · 2026-03-31
Revenue$173.9M
Net Income$7.3M
Total Assets$1.43B
Stockholders' Equity$764.6M
Operating Cash Flow$24.5M

keid analysis is for reference only and does not constitute investment advice.